Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy
Darrell H S Tan, Keith Chan, Janet Raboud, et al.
The Lancet. HIV
|
August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Steve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
Frontiers in Oncology
|
April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer
Josephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
Journal of Comparative Effectiveness Research
|
November 3, 2020
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer
Sam T Keeping, Shannon Cope, Keith Chan, et al.
Ultrasound in Medicine & Biology
|
September 17, 2023
Comparative Study of Histotripsy Pulse Parameters Used to Inactivate Escherichia coli in Suspension
Pratik A Ambekar, Yak-Nam Wang, Tatiana Khokhlova, et al.
Journal of the International Association of Providers of AIDS Care
|
December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada
Alexis K Palmer, Angela Cescon, Keith Chan, et al.
Advances in Therapy
|
March 18, 2024
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M H Chen, Ina Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 13, 2018
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody Efficacy
Lekh N Dahal, Chie-Yin Huang, Richard J Stopforth, et al.
Plos One
|
January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study
Angela Cescon, Sophie Patterson, Keith Chan, et al.
BMC Infectious Diseases
|
July 18, 2015
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Sophie Patterson, Angela Cescon, Hasina Samji, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy
Darrell H S Tan, Keith Chan, Janet Raboud, et al.
The Lancet. HIV
|
August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
Steve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
Frontiers in Oncology
|
April 21, 2023
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer
Josephine Louella Feliciano, Dylan McLoone, Yingxin Xu, et al.
Journal of Comparative Effectiveness Research
|
November 3, 2020
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer
Sam T Keeping, Shannon Cope, Keith Chan, et al.
Ultrasound in Medicine & Biology
|
September 17, 2023
Comparative Study of Histotripsy Pulse Parameters Used to Inactivate Escherichia coli in Suspension
Pratik A Ambekar, Yak-Nam Wang, Tatiana Khokhlova, et al.
Journal of the International Association of Providers of AIDS Care
|
December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada
Alexis K Palmer, Angela Cescon, Keith Chan, et al.
Advances in Therapy
|
March 18, 2024
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
Gilles Salles, Jenny M H Chen, Ina Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 13, 2018
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody Efficacy
Lekh N Dahal, Chie-Yin Huang, Richard J Stopforth, et al.
Plos One
|
January 7, 2014
Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study
Angela Cescon, Sophie Patterson, Keith Chan, et al.
BMC Infectious Diseases
|
July 18, 2015
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Sophie Patterson, Angela Cescon, Hasina Samji, et al.
Page
of 12